1. Home
  2. LGCB vs SYBX Comparison

LGCB vs SYBX Comparison

Compare LGCB & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • SYBX
  • Stock Information
  • Founded
  • LGCB 2011
  • SYBX N/A
  • Country
  • LGCB Japan
  • SYBX United States
  • Employees
  • LGCB N/A
  • SYBX N/A
  • Industry
  • LGCB
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • SYBX Health Care
  • Exchange
  • LGCB Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • LGCB 16.7M
  • SYBX 16.4M
  • IPO Year
  • LGCB 2023
  • SYBX N/A
  • Fundamental
  • Price
  • LGCB $1.91
  • SYBX $1.69
  • Analyst Decision
  • LGCB
  • SYBX
  • Analyst Count
  • LGCB 0
  • SYBX 0
  • Target Price
  • LGCB N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • LGCB 64.7K
  • SYBX 17.9K
  • Earning Date
  • LGCB 07-03-2025
  • SYBX 11-11-2025
  • Dividend Yield
  • LGCB N/A
  • SYBX N/A
  • EPS Growth
  • LGCB N/A
  • SYBX N/A
  • EPS
  • LGCB N/A
  • SYBX N/A
  • Revenue
  • LGCB $8,993,265.00
  • SYBX N/A
  • Revenue This Year
  • LGCB N/A
  • SYBX N/A
  • Revenue Next Year
  • LGCB N/A
  • SYBX N/A
  • P/E Ratio
  • LGCB N/A
  • SYBX N/A
  • Revenue Growth
  • LGCB 5.80
  • SYBX N/A
  • 52 Week Low
  • LGCB $1.22
  • SYBX $0.90
  • 52 Week High
  • LGCB $6.83
  • SYBX $1.96
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 37.35
  • SYBX 56.21
  • Support Level
  • LGCB $1.77
  • SYBX $1.61
  • Resistance Level
  • LGCB $2.41
  • SYBX $1.74
  • Average True Range (ATR)
  • LGCB 0.20
  • SYBX 0.08
  • MACD
  • LGCB -0.04
  • SYBX -0.01
  • Stochastic Oscillator
  • LGCB 38.40
  • SYBX 41.67

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: